Home › Compare › EXDI vs BTI

EXDI vs BTI: Dividend Comparison 2026

EXDI yields 3076.92% · BTI yields 5.38%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EXDI wins by $578804600665.46M in total portfolio value
10 years
EXDI
EXDI
● Live price
3076.92%
Share price
$0.07
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$578804600665.50M
Annual income
$544,023,840,488,516,100.00
Full EXDI calculator →
BTI
BTI
● Live price
5.38%
Share price
$58.47
Annual div
$3.15
5Y div CAGR
11.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.7K
Annual income
$2,786.64
Full BTI calculator →

Portfolio growth — EXDI vs BTI

📍 EXDI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEXDIBTI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EXDI + BTI cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
EXDI pays
BTI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EXDI
Annual income on $10K today (after 15% tax)
$261,538.46/yr
After 10yr DRIP, annual income (after tax)
$462,420,264,415,238,660.00/yr
BTI
Annual income on $10K today (after 15% tax)
$457.40/yr
After 10yr DRIP, annual income (after tax)
$2,368.64/yr
At 15% tax rate, EXDI beats the other by $462,420,264,415,236,300.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EXDI + BTI for your $10,000?

EXDI: 50%BTI: 50%
100% BTI50/50100% EXDI
Portfolio after 10yr
$289402300332.77M
Annual income
$272,011,920,244,259,460.00/yr
Blended yield
93.99%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

EXDI
No analyst data
BTI
Analyst Ratings
12
Buy
4
Hold
2
Sell
Consensus: Buy
Price Target
$40.00
-31.6% upside vs current
Range: $40.00 — $40.00
Altman Z
2.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EXDI buys
0
BTI buys
0
No recent congressional trades found for EXDI or BTI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEXDIBTI
Forward yield3076.92% ✓5.38%
Annual dividend / share$2.00$3.15 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%11.3% ✓
Portfolio after 10y$578804600665.50M ✓$37.7K
Annual income after 10y$544,023,840,488,516,100.00 ✓$2,786.64
Total dividends collected$576403114825.48M ✓$14.3K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: EXDI vs BTI ($10,000, DRIP)

YearEXDI PortfolioEXDI Income/yrBTI PortfolioBTI Income/yrGap
1← crossover$318,392$307,692.31$11,299$598.92+$307.1K → EXDI
2$9,496,461$9,155,781.67$12,794$703.91+$9.48M → EXDI
3$265,378,974$255,217,760.17$14,518$829.07+$265.36M → EXDI
4$6,949,441,440$6,665,485,937.77$16,513$978.64+$6949.42M → EXDI
5$170,564,997,752$163,129,095,411.51$18,827$1,157.84+$170564.98M → EXDI
6$3,924,365,658,393$3,741,861,110,798.54$21,518$1,373.12+$3924365.64M → EXDI
7$84,659,703,250,880$80,460,631,996,399.20$24,657$1,632.46+$84659703.23M → EXDI
8$1,712,795,370,094,185$1,622,209,487,615,743.00$28,329$1,945.74+$1712795370.07M → EXDI
9$32,505,383,342,974,930$30,672,692,296,974,148.00$32,637$2,325.33+$32505383342.94M → EXDI
10$578,804,600,665,499,400$544,023,840,488,516,100.00$37,708$2,786.64+$578804600665.46M → EXDI

EXDI vs BTI: Complete Analysis 2026

EXDI — Stock

Exactus, Inc. produces and supplies hemp-derived ingredients and feminized hemp genetics. It provides cannabidiol (CBD) feminized genetics, high cannabigerol (CBG) feminized genetics, hemp-derived specialty ingredients, and white-label products to the cosmetic, wellness, food, beverage, pharmaceutical, and pet industries. The company's specialty ingredients include CBD, CBG, CBN, and CBC isolates; CBD and CBG distillates; CBD water-soluble; CBD and CBG biomass; CBD AND CBG flowers; and CBD crude oil. It also provides a range of custom manufactured specialty cannabinoid products, such as skincare products, pain creams, tinctures, bath bombs, soft gels, balms, pet products, supplements, and other products. The company is based in Delray Beach, Florida. Exactus, Inc. is a subsidiary of Ceed2Med, LLC.

Full EXDI Calculator →

BTI — Consumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →
📬

Get this EXDI vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EXDI vs SCHDEXDI vs JEPIEXDI vs OEXDI vs KOEXDI vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.